Lord JD - Search Results

1

Paradoxically increased FOXP3+ T cells in IBD do not preferentially express the isoform of FOXP3 lacking exon 2.

Lord JD, Valliant-Saunders K, Hahn H, Thirlby RC, Ziegler SF. Lord JD, et al. Dig Dis Sci. 2012 Nov;57(11):2846-55. doi: 10.1007/s10620-012-2292-3. Epub 2012 Jun 27. Dig Dis Sci. 2012. PMID: 22736020 Free PMC article.

2

Refractory colitis following anti-CTLA4 antibody therapy: analysis of mucosal FOXP3+ T cells.

Lord JD, Hackman RC, Moklebust A, Thompson JA, Higano CS, Chielens D, Steinbach G, McDonald GB. Lord JD, et al. Dig Dis Sci. 2010 May;55(5):1396-405. doi: 10.1007/s10620-009-0839-8. Epub 2009 Jun 9. Dig Dis Sci. 2010. PMID: 19507029 Free PMC article.

3

Blood and gastric FOXP3+ T cells are not decreased in human gastric graft-versus-host disease.

Lord JD, Hackman RC, Gooley TA, Wood BL, Moklebust AC, Hockenbery DM, Steinbach G, Ziegler SF, McDonald GB. Lord JD, et al. Biol Blood Marrow Transplant. 2011 Apr;17(4):486-96. doi: 10.1016/j.bbmt.2010.09.015. Epub 2010 Sep 24. Biol Blood Marrow Transplant. 2011. PMID: 20870026 Free PMC article.

4

T-cell receptor sequencing reveals the clonal diversity and overlap of colonic effector and FOXP3+ T cells in ulcerative colitis.

Lord J, Chen J, Thirlby RC, Sherwood AM, Carlson CS. Lord J, et al. Inflamm Bowel Dis. 2015 Jan;21(1):19-30. doi: 10.1097/MIB.0000000000000242. Inflamm Bowel Dis. 2015. PMID: 25437819 Free PMC article.

5

Human Blood and Mucosal Regulatory T Cells Express Activation Markers and Inhibitory Receptors in Inflammatory Bowel Disease.

Lord JD, Shows DM, Chen J, Thirlby RC. Lord JD, et al. PLoS One. 2015 Aug 25;10(8):e0136485. doi: 10.1371/journal.pone.0136485. eCollection 2015. PLoS One. 2015. PMID: 26305224 Free PMC article.

6

Promises and paradoxes of regulatory T cells in inflammatory bowel disease.

Lord JD. Lord JD. World J Gastroenterol. 2015 Oct 28;21(40):11236-45. doi: 10.3748/wjg.v21.i40.11236. World J Gastroenterol. 2015. PMID: 26523099 Free PMC article. Review.

7

CD4 T Cells in IBD: Crossing the Line?

Boden EK, Lord JD. Boden EK, et al. Among authors: lord jd. Dig Dis Sci. 2017 Sep;62(9):2208-2210. doi: 10.1007/s10620-017-4655-2. Epub 2017 Jun 23. Dig Dis Sci. 2017. PMID: 28646283 No abstract available.

8

Identification of Candidate Biomarkers Associated with Response to Vedolizumab in Inflammatory Bowel Disease.

Boden EK, Shows DM, Chiorean MV, Lord JD. Boden EK, et al. Among authors: lord jd. Dig Dis Sci. 2018 Sep;63(9):2419-2429. doi: 10.1007/s10620-018-4924-8. Epub 2018 Jan 25. Dig Dis Sci. 2018. PMID: 29372476

9

Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells.

Bollyky PL, Lord JD, Masewicz SA, Evanko SP, Buckner JH, Wight TN, Nepom GT. Bollyky PL, et al. Among authors: lord jd. J Immunol. 2007 Jul 15;179(2):744-7. doi: 10.4049/jimmunol.179.2.744. J Immunol. 2007. PMID: 17617562

10

ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors.

Bollyky PL, Wu RP, Falk BA, Lord JD, Long SA, Preisinger A, Teng B, Holt GE, Standifer NE, Braun KR, Xie CF, Samuels PL, Vernon RB, Gebe JA, Wight TN, Nepom GT. Bollyky PL, et al. Among authors: lord jd. Proc Natl Acad Sci U S A. 2011 May 10;108(19):7938-43. doi: 10.1073/pnas.1017360108. Epub 2011 Apr 25. Proc Natl Acad Sci U S A. 2011. PMID: 21518860 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page